The U.S. District Court for the Eastern District of Texas has set a November 1, 2010 trial date for Digital-Vending Services International Inc.’s patent infringement complaint against Apollo Group, Inc.…
Merck & Co. Inc. and E.I. du Pont de Nemours are pursuing patent infringement proceedings against various companies in Portugal, Spain, Norway and Austria.
In Europe, the Company is aware of…
Merck & Co. Inc. continues to pursue a patent infringement lawsuit against Lupin Ltd.
The Company and AstraZeneca received notice in September 2009 that Lupin had filed an ANDA for esomeprazole…
Merck & Co. Inc. is cooperating with the U.S. Federal Trade Commission in responding to a Civil Investigative Demand regarding the settlement of the Ranbaxy patent suit.
The Company and AstraZeneca…
Verwertungsgesellschaft Wort’s suit against Canon Inc. over copyright levies relating to the Company’s single-function printers sold in Germany remains pending.
In Germany, VG Wort, a collecting agency representing certain copyright holders,…
Merck & Co., Inc.’s patent infringement suit against Sandoz Inc. is scheduled to go to trial in December 2010.
In January 2009, the company received notice from Sandoz that it had…
Monsanto Co.’s remaining patent infringement claims against Pioneer Hi-Bred International, Inc., a wholly owned subsidiary of E. I. du Pont de Nemours and Company, are set for trial on Sept.…
Lupin Ltd. and Lupin Pharmaceuticals continue to challenge Genzyme Corporation’s U.S. Patent No. 5,667,775, which expires in 2014.
The Company received notice in 2009 from Lupin that it had submitted to…
Cardiofocus, Inc.’s patent infringement suit against Candela Corporation remains stayed pending the U.S. Patent & Trademark Office’s re-examination proceedings.
On Feb. 19, 2008, Cardiofocus filed suit against the Company and eight…
The U.S. District Court for the District of Massachusetts has yet to rule on Palomar Medical Technologies, Inc.’s motion to lift the stay in its patent infringement action against Candela…